Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Testosterone Deficiency in Hypertensive Men: Prevalence and Associated Factors.
Negretto LAF, Rassi N, Soares LR, Saraiva ABC, Teixeira MEF, Santos LDR, Souza ALL, Jardim PCBV, Barroso de Souza WKS, Jardim TSV. Negretto LAF, et al. Among authors: rassi n. Arq Bras Cardiol. 2024 Apr 5;121(3):e20230138. doi: 10.36660/abc.20230138. eCollection 2024. Arq Bras Cardiol. 2024. PMID: 38597552 Free article. English, Portuguese.
A Multilab Replication of the Ego Depletion Effect.
Dang J, Barker P, Baumert A, Bentvelzen M, Berkman E, Buchholz N, Buczny J, Chen Z, De Cristofaro V, de Vries L, Dewitte S, Giacomantonio M, Gong R, Homan M, Imhoff R, Ismail I, Jia L, Kubiak T, Lange F, Li DY, Livingston J, Ludwig R, Panno A, Pearman J, Rassi N, Schiöth HB, Schmitt M, Sevincer AT, Shi J, Stamos A, Tan YC, Wenzel M, Zerhouni O, Zhang LW, Zhang YJ, Zinkernagel A. Dang J, et al. Among authors: rassi n. Soc Psychol Personal Sci. 2021 Jan 1;12(1):14-24. doi: 10.1177/1948550619887702. Epub 2020 Apr 3. Soc Psychol Personal Sci. 2021. PMID: 34113424 Free PMC article.
Switching from originator recombinant growth hormone (Genotropin™) to biosimilar (CRISCY™): Results from a 6-month, multicentric, non-inferiority, extension trial.
Czepielewski MA, Garret Q, Vencio SAC, Rassi N, Faria MS, Senn CCP, Bronstein MD, Cerqueira MJAG, Neves ACL, Spinola-Castro AM, Cunha MPR, Leite NR, Wassermann GE, Alegria MC, Toffoletto O, Afiune J, Baradelli R, Rodrigues DG, Scharf M. Czepielewski MA, et al. Among authors: rassi n. Growth Horm IGF Res. 2021 Feb;56:101372. doi: 10.1016/j.ghir.2020.101372. Epub 2020 Nov 28. Growth Horm IGF Res. 2021. PMID: 33260063 Clinical Trial.
Efficacy and safety of a biosimilar recombinant human growth hormone (r-hGH Cristalia) compared with reference r-hGH in children with growth hormone deficiency (CERES study): A randomized, multicentric, investigator-blind, phase 3 trial.
Czepielewski MA, Garret Q, Vencio SAC, Rassi N, Felicio JS, Faria MS, Senn CCP, Bronstein MD, Cerqueira MJAG, Neves ACL, Sgarbi JA, Spinola-Castro AM, Cunha MPR, Bandeira F, Toffoletto O, Afiune J, Baradelli R, Rodrigues DG, Scharf M. Czepielewski MA, et al. Among authors: rassi n. Growth Horm IGF Res. 2019 Oct-Dec;48-49:29-35. doi: 10.1016/j.ghir.2019.07.003. Epub 2019 Aug 2. Growth Horm IGF Res. 2019. PMID: 31493626 Clinical Trial.
Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial.
Bhatt DL, Steg PG, Mehta SR, Leiter LA, Simon T, Fox K, Held C, Andersson M, Himmelmann A, Ridderstråle W, Chen J, Song Y, Diaz R, Goto S, James SK, Ray KK, Parkhomenko AN, Kosiborod MN, McGuire DK, Harrington RA; THEMIS Steering Committee and Investigators. Bhatt DL, et al. Lancet. 2019 Sep 28;394(10204):1169-1180. doi: 10.1016/S0140-6736(19)31887-2. Epub 2019 Sep 1. Lancet. 2019. PMID: 31484629 Free article. Clinical Trial.
Ticagrelor in Patients with Stable Coronary Disease and Diabetes.
Steg PG, Bhatt DL, Simon T, Fox K, Mehta SR, Harrington RA, Held C, Andersson M, Himmelmann A, Ridderstråle W, Leonsson-Zachrisson M, Liu Y, Opolski G, Zateyshchikov D, Ge J, Nicolau JC, Corbalán R, Cornel JH, Widimský P, Leiter LA; THEMIS Steering Committee and Investigators. Steg PG, et al. N Engl J Med. 2019 Oct 3;381(14):1309-1320. doi: 10.1056/NEJMoa1908077. Epub 2019 Sep 1. N Engl J Med. 2019. PMID: 31475798 Free article. Clinical Trial.
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial.
Heerspink HJL, Parving HH, Andress DL, Bakris G, Correa-Rotter R, Hou FF, Kitzman DW, Kohan D, Makino H, McMurray JJV, Melnick JZ, Miller MG, Pergola PE, Perkovic V, Tobe S, Yi T, Wigderson M, de Zeeuw D; SONAR Committees and Investigators. Heerspink HJL, et al. Lancet. 2019 May 11;393(10184):1937-1947. doi: 10.1016/S0140-6736(19)30772-X. Epub 2019 Apr 14. Lancet. 2019. PMID: 30995972 Clinical Trial.
Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes.
Holman RR, Bethel MA, Mentz RJ, Thompson VP, Lokhnygina Y, Buse JB, Chan JC, Choi J, Gustavson SM, Iqbal N, Maggioni AP, Marso SP, Öhman P, Pagidipati NJ, Poulter N, Ramachandran A, Zinman B, Hernandez AF; EXSCEL Study Group. Holman RR, et al. N Engl J Med. 2017 Sep 28;377(13):1228-1239. doi: 10.1056/NEJMoa1612917. Epub 2017 Sep 14. N Engl J Med. 2017. PMID: 28910237 Free PMC article. Clinical Trial.
41 results